Kyung Dong Pharmaceutical Co., Ltd. (KOSDAQ:011040)

Kyung Dong Pharmaceutical Revenue

Kyung Dong Pharmaceutical had revenue of 52.26B KRW in the quarter ending June 30, 2026, with 5.76% growth. This brings the company's total for the last twelve months to 201.12B, up 3.46% year-over-year. In the year 2025, Kyung Dong Pharmaceutical had annual revenue of 196.27B with 1.20% growth. That makes Kyung Dong Pharmaceutical the 19,513th largest company in the world by revenue and 1,030th in South Korea.

• Revenue (ttm): 201.12B
• Revenue Growth: +3.46%
• P/S Ratio: 0.71
• Revenue / Employee: 605.78M
• Employees: 332
• Market Cap: 143.57B

Revenue Chart

Chart

Chart

Revenue by Segment

By Segment

Chart

• Pharmaceutical Sector 187.49B 94.5%
• Others 6.74B 3.4%
• Rental Sector 4.11B 2.1%

By Geography

Chart

• South Korea 195.83B 99.8%
• United States of America 443.45M 0.2%

Fiscal year ended Dec 31, 2025 See the full Kyung Dong Pharmaceutical breakdown

Revenue History

Fiscal Year End	Revenue	Change	Growth
Dec 31, 2025	196.27B	2.34B	1.20%
Dec 31, 2024	193.94B	31.26B	19.22%
Dec 31, 2023	162.67B	-20.04B	-10.97%
Dec 31, 2022	182.72B	5.11B	2.88%
Dec 31, 2021	177.61B	3.78B	2.18%

Data Source: S&P Global Market Intelligence Last updated: Aug 14, 2026

Revenue data is provided by S&P Global Market Intelligence and updates within hours after each earnings release, which is every three months for this company.

Update frequency:

Quarterly

Last checked:

Oct 22, 2026

Data Sources Report a data error